|
1
|
Divine LM and Huh WK: Tertiary prevention
of cervical cancer. Clin Obstet Gynecol. 57:316–324. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vizcaino AP, Moreno V, Bosch FX, Muñoz N,
Barros-Dios XM, Borras J and Parkin DM: International trends in
incidence of cervical cancer: II. Squamous-cell carcinoma. Int J
Cancer. 86:429–435. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vizcaino AP, Moreno V, Bosch FX, Muñoz N,
Barros-Dios XM and Parkin DM: International trends in the incidence
of cervical cancer: I. Adenocarcinoma and adenosquamous cell
carcinomas. Int J Cancer. 75:536–545. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li J, Kang LN and Qiao YL: Review of the
cervical cancer disease burden in mainland China. Asian Pac J
Cancer Prev. 12:1149–1153. 2011.PubMed/NCBI
|
|
5
|
Burd EM: Human papillomavirus and cervical
cancer. Clin Microbiol Rev. 16:1–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kumar V, Abbas AK, Fausto N and Mitchell
RN: Robbins Basic Pathology. Saunders Elsevier; Dublin: 2007
|
|
7
|
Waxman AG, Chelmow D, Darragh TM, Lawson H
and Moscicki AB: Revised terminology for cervical histopathology
and its implications for management of high-grade squamous
intraepithelial lesions of the cervix. Obstet Gynecol.
120:1465–1471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Agorastos T, Miliaras D, Lambropoulos AF,
Chrisafi S, Kotsis A, Manthos A and Bontis J: Detection and typing
of human papillomavirus DNA in uterine cervices with coexistent
grade I and grade III intraepithelial neoplasia: Biologic
progression or independent lesions? Eur J Obstet Gynecol Reprod
Biol. 121:99–103. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leda G, Akila NV, Carlos AP, William PT
and Sharmila M: Cervical Cancer. http://www.cancernetwork.com/cancer-management/cervicalNov
01–2015
|
|
10
|
Jin B, Li Y and Robertson KD: DNA
methylation: Superior or subordinate in the epigenetic hierarchy?
Genes Cancer. 2:607–617. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee JY and Soong SJ: Cancer mortality in
the South, 1950 to 1980. South Med J. 83:185–190. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Joshi S, Kulkarni V, Darak T, Mahajan U,
Srivastava Y, Gupta S, Krishnan S, Mandolkar M and Bharti AC:
Cervical cancer screening and treatment of cervical intraepithelial
neoplasia in female sex workers using ‘screen and treat’ approach.
Int J Womens Health. 7:477–483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pak SC, Martens M, Bekkers R, Crandon AJ,
Land R, Nicklin JL, Perrin LC and Obermair A: Pap smear screening
history of women with squamous cell carcinoma and adenocarcinoma of
the cervix. Aust N Z J Obstet Gynaecol. 47:504–507. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Geldenhuys L and Murray ML: Sensitivity
and specificity of the Pap smear for glandular lesions of the
cervix and endometrium. Acta Cytol. 51:47–50. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nanda K, McCrory DC, Myers ER, Bastian LA,
Hasselblad V, Hickey JD and Matchar DB: Accuracy of the
Papanicolaou test in screening for and follow-up of cervical
cytologic abnormalities: A systematic review. Ann Intern Med.
132:810–819. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lazcano-Ponce E, Alonso P, Ruiz-Moreno JA
and Hernández-Avila M: Recommendations for cervical cancer
screening programs in developing countries. The need for equity and
technological development. Salud Publica Mex. 45 Suppl 3:S449–S462.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nuovo J, Melnikow J and Howell LP: New
tests for cervical cancer screening. Am Fam Physician. 64:780–786.
2001.PubMed/NCBI
|
|
18
|
Flores-Miramontes MG, Torres-Reyes LA,
Alvarado-Ruíz L, Romero-Martínez SA, Ramírez-Rodríguez V,
Balderas-Peña LM, Vallejo-Ruíz V, Piña-Sánchez P, Cortés-Gutiérrez
EI, Jave-Suárez LF and Aguilar-Lemarroy A: Human papillomavirus
genotyping by linear array and next-generation Sequencing in
cervical samples from Western Mexico. Virol J. 12:1612015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Othman N and Othman NH: Detection of human
papillomavirus DNA in routine cervical scraping samples: Use for a
national cervical cancer screening program in a developing nation.
Asian Pac J Cancer Prev. 15:2245–2249. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Natter C, Polterauer S, Rahhal-Schupp J,
Cacsire Castillo-Tong D, Pils S, Speiser P, Zeillinger R, Heinze G
and Grimm C: Association of TAP gene polymorphisms and risk of
cervical intraepithelial neoplasia. Dis Markers. 35:79–84. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cuzick J, Clavel C, Petry KU, Meijer CJ,
Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni
P and Iftner T: Overview of the European and North American studies
on HPV testing in primary cervical cancer screening. Int J Cancer.
119:1095–1101. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Whitlock EP, Vesco KK, Eder M, Lin JS,
Senger CA and Burda BU: Liquid-based cytology and human
papillomavirus testing to screen for cervical cancer: A systematic
review for the U.S. Preventive Services Task Force. Ann Intern Med.
155:687–697, W214-W215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Loscalzo J and Handy DE: Epigenetic
modifications: Basic mechanisms and role in cardiovascular disease
(2013 Grover Conference series). Pulm Circ. 4:169–174. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sakamoto A, Akiyama Y, Shimada S, Zhu WG,
Yuasa Y and Tanaka S: DNA Methylation in the Exon 1 region and
complex regulation of Twist1 expression in gastric cancer cells.
PLoS One. 10:e01456302015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fan H, Zhang H, Pascuzzi PE and Andrisani
O: Hepatitis B virus X protein induces EpCAM expression via active
DNA demethylation directed by RelA in complex with EZH2 and TET2.
Oncogene. 35:715–726. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schmid CA, Robinson MD, Scheifinger NA,
Müller S, Cogliatti S, Tzankov A and Müller A: DUSP4 deficiency
caused by promoter hypermethylation drives JNK signaling and tumor
cell survival in diffuse large B cell lymphoma. J Exp Med.
212:775–792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sood S and Srinivasan R: Alterations in
gene promoter methylation and transcript expression induced by
cisplatin in comparison to 5-Azacytidine in HeLa and SiHa cervical
cancer cell lines. Mol Cell Biochem. 404:181–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kulis M and Esteller M: DNA methylation
and cancer. Adv Genet. 70:27–56. 2010.PubMed/NCBI
|
|
29
|
Chao TK, Ke FY, Liao YP, Wang HC, Yu CP
and Lai HC: Triage of cervical cytological diagnoses of atypical
squamous cells by DNA methylation of paired boxed gene 1 (PAX1).
Diagn Cytopathol. 41:41–46. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lai HC, Lin YW, Huang RL, Chung MT, Wang
HC, Liao YP, Su PH, Liu YL and Yu MH: Quantitative DNA methylation
analysis detects cervical intraepithelial neoplasms type 3 and
worse. Cancer. 116:4266–4274. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lai HC, Lin YW, Huang TH, Yan P, Huang RL,
Wang HC, Liu J, Chan MW, Chu TY, Sun CA, et al: Identification of
novel DNA methylation markers in cervical cancer. Int J Cancer.
123:161–167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hammou JC, Bertino B, Blancheri A, Kon Man
P and Patoz L: Pap test: Liquid-based-thin-layer. A new method:
Results. Gynecol Obstet Fertil. 31:833–840. 2003.(In French).
|
|
33
|
WHO, . An introduction to cervical
intraepithelial neoplasia (CIN). http://screening.iarc.fr/colpochap.php?chap=2Aug
15–2015
|
|
34
|
Elias JM, Margiotta M and Gaborc D:
Sensitivity and detection efficiency of the peroxidase
antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and
peroxidase-labeled avidin-biotin (LAB) methods. Am J Clin Pathol.
92:62–67. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu J, Xu L, Yang BH, Wang LF, Lin X and Tu
H: Assessing methylation status of PAX1 in cervical scrapings, as a
novel diagnostic and predictive biomarker, was closely related to
screen cervical cancer. Int J Clin Exp Pathol. 8:1674–1681.
2015.PubMed/NCBI
|
|
36
|
Wehr R and Gruss P: Pax and vertebrate
development. Int J Dev Biol. 40:369–377. 1996.PubMed/NCBI
|
|
37
|
Feiner N, Meyer A and Kuraku S: Evolution
of the vertebrate Pax4/6 class of genes with focus on its novel
member, the Pax10 gene. Genome Biol Evol. 6:1635–1651. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lang D, Powell SK, Plummer RS, Young KP
and Ruggeri BA: PAX genes: Roles in development, pathophysiology,
and cancer. Biochem Pharmacol. 73:1–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lang D, Lu MM, Huang L, Engleka KA, Zhang
M, Chu EY, Lipner S, Skoultchi A, Millar SE and Epstein JA: Pax3
functions at a nodal point in melanocyte stem cell differentiation.
Nature. 433:884–887. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sharma R, Sanchez-Ferras O and Bouchard M:
Pax genes in renal development, disease and regeneration. Semin
Cell Dev Biol. 44:97–106. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hurtado A, Holmes KA, Geistlinger TR,
Hutcheson IR, Nicholson RI, Brown M, Jiang J, Howat WJ, Ali S and
Carroll JS: Regulation of ERBB2 by oestrogen receptor-PAX2
determines response to tamoxifen. Nature. 456:663–666. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Galili N, Davis RJ, Fredericks WJ,
Mukhopadhyay S, Rauscher FJ III, Emanuel BS, Rovera G and Barr FG:
Fusion of a fork head domain gene to PAX3 in the solid tumour
alveolar rhabdomyosarcoma. Nat Genet. 5:230–235. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bennicelli JL, Advani S, Schäfer BW and
Barr FG: PAX3 and PAX7 exhibit conserved cis-acting transcription
repression domains and utilize a common gain of function mechanism
in alveolar rhabdomyosarcoma. Oncogene. 18:4348–4356. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu W, Li X, Chu ES, Go MY, Xu L, Zhao G,
Li L, Dai N, Si J, Tao Q, et al: Paired box gene 5 is a novel tumor
suppressor in hepatocellular carcinoma through interaction with p53
signaling pathway. Hepatology. 53:843–853. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
McGaughran JM, Oates A, Donnai D, Read AP
and Tassabehji M: Mutations in PAX1 may be associated with
Klippel-Feil syndrome. Eur J Hum Genet. 11:468–474. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bannykh SI, Emery SC, Gerber JK, Jones KL,
Benirschke K and Masliah E: Aberrant Pax1 and Pax9 expression in
Jarcho-Levin syndrome: Report of two Caucasian siblings and
literature review. Am J Med Genet A. 120A:1–246. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Schnittger S, Rao VV, Deutsch U, Gruss P,
Balling R and Hansmann I: Pax1, a member of the paired
box-containing class of developmental control genes, is mapped to
human chromosome 20p11.2 by in situ hybridization (ISH and FISH).
Genomics. 14:740–744. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang Y, Chen FQ, Sun YH, Zhou SY, Li TY
and Chen R: Effects of DNMT1 silencing on malignant phenotype and
methylated gene expression in cervical cancer cells. J Exp Clin
Cancer Res. 30:982011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Huang TH, Lai HC, Liu HW, Lin CJ, Wang KH,
Ding DC and Chu TY: Quantitative analysis of methylation status of
the PAX1 gene for detection of cervical cancer. Int J Gynecol
Cancer. 20:513–519. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen W, Yang HJ, Xu J and Zhu HP:
Quantitative analysis of LMX1A and PAX1 gene methylation in
cervical cancer and cervical intraepithelial neoplasia. China
Oncol. 25:19–24. 2015.
|
|
51
|
Kan YY, Liou YL, Wang HJ, Chen CY, Sung
LC, Chang CF and Liao CI: PAX1 methylation as a potential biomarker
for cervical cancer screening. Int J Gynecol Cancer. 24:928–934.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lai HC, Ou YC, Chen TC, Huang HJ, Cheng
YM, Chen CH, Chu TY, Hsu ST, Liu CB, Hung YC, et al: PAX1/SOX1 DNA
methylation and cervical neoplasia detection: A Taiwanese
Gynecologic Oncology Group (TGOG) study. Cancer Med. 3:1062–1074.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lim EH, Ng SL, Li JL, Chang AR, Ng J,
Ilancheran A, Low J, Quek SC and Tay EH: Cervical dysplasia:
Assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2,
PAX1 and TFPI2 to improve diagnostic accuracy. Gynecol Oncol.
119:225–231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
German MS, Wang J, Fernald AA, Espinosa R
III, Le Beau MM and Bell GI: Localization of the genes encoding two
transcription factors, LMX1 and CDX3, regulating insulin gene
expression to human chromosomes 1 and 13. Genomics. 24:403–404.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Dong W, Feng L, Xie Y, Zhang H and Wu Y:
Hypermethylation-mediated reduction of LMX1A expression in gastric
cancer. Cancer Sci. 102:361–366. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhao Y, Guo S, Sun J, Huang Z, Zhu T,
Zhang H, Gu J, He Y, Wang W, Ma K, et al: Methylcap-seq reveals
novel DNA methylation markers for the diagnosis and recurrence
prediction of bladder cancer in a Chinese population. PLoS One.
7:e351752012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Su HY, Lai HC, Lin YW, Chou YC, Liu CY and
Yu MH: An epigenetic marker panel for screening and prognostic
prediction of ovarian cancer. Int J Cancer. 124:387–393. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hagihara A, Miyamoto K, Furuta J, Hiraoka
N, Wakazono K, Seki S, Fukushima S, Tsao MS, Sugimura T and
Ushijima T: Identification of 27 5′ CpG islands aberrantly
methylated and 13 genes silenced in human pancreatic cancers.
Oncogene. 23:8705–8710. 2004. View Article : Google Scholar : PubMed/NCBI
|
